NASDAQ:OM

Outset Medical (OM) Stock Price, News & Analysis

Outset Medical logo
$3.16 -0.23 (-6.78%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$3.22 +0.06 (+1.90%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Outset Medical Stock (NASDAQ:OM)

Advanced

Key Stats

Today's Range
$3.12
▼
$3.36
50-Day Range
$2.96
▼
$4.44
52-Week Range
$2.84
▼
$6.49
Volume
142,514 shs
Average Volume
107,148 shs
Market Capitalization
$59.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
Consensus Rating
Hold

Company Overview

Outset Medical is a medical technology company that develops and sells products for hemodialysis, a treatment that filters waste and excess fluid from the blood. Its main product is the Tablo Hemodialysis System, an integrated dialysis platform designed for use in hospitals, clinics and home settings.

Tablo combines dialysis equipment with water purification and a touchscreen interface, aiming to simplify treatment setup and operation. The system also supports access to treatment data through connected software tools.

Founded in 2003 and headquartered in San Jose, California, Outset Medical focuses on expanding access to dialysis care through its Tablo platform. The company serves healthcare providers and patients, with its products designed for both professional care environments and home use.

AI Generated. May Contain Errors.

Outset Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
65th Percentile Overall Score

OM MarketRank™: 
3.268871699115 of 5 stars

Outset Medical scored higher than 65% of companies evaluated by MarketBeat, and ranked 270th out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Outset Medical has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Outset Medical has a consensus price target of $10.00, representing about 216.5% upside from its current price of $3.16.

  • Amount of Analyst Coverage

    Outset Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Outset Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Outset Medical are expected to grow in the coming year, from ($3.51) to ($2.79) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Outset Medical is -0.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Outset Medical is -0.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Outset Medical has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.42% of the float of Outset Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Outset Medical has a short interest ratio ("days to cover") of 8.61.
  • Change versus previous month

    Short interest in Outset Medical has recently decreased by 12.85%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Outset Medical does not currently pay a dividend.

  • Dividend Growth

    Outset Medical does not have a long track record of dividend growth.

  • News Sentiment

    Outset Medical has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Outset Medical this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added Outset Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $28,997.00 in company stock.

  • Percentage Held by Insiders

    2.50% of the stock of Outset Medical is held by insiders.

  • Percentage Held by Institutions

    Outset Medical has minimal institutional ownership at this time.

  • Read more about Outset Medical's insider trading history.
Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OM Stock News Headlines

Outset Medical Earnings Call Highlights Growth and Risks
Outset Medical (OM) Receives a Buy from Stifel Nicolaus
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
Outset Medical (OM) Receives a Buy from TD Cowen
Outset Medical, Inc. (OM) Q3 2026 Earnings Call Transcript
Outset Medical (OM) Q3 2026 Earnings Call Transcript
See More Headlines

OM Stock Analysis - Frequently Asked Questions

Outset Medical's stock was trading at $3.71 at the beginning of the year. Since then, OM stock has decreased by 14.8% and is now trading at $3.16.

Outset Medical, Inc. (NASDAQ:OM) issued its earnings results on Wednesday, November, 4th. The company reported ($0.68) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.69) by $0.01. The company earned $33.60 million during the quarter, compared to analyst estimates of $31.40 million. Outset Medical had a negative trailing twelve-month return on equity of 66.98% and a negative net margin of 58.33%.
Read the conference call transcript
.

Outset Medical shares reverse split on the morning of Thursday, March 20th 2025.The 1-15 reverse split was announced on Tuesday, March 18th 2025. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, March 19th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Outset Medical (OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Top institutional investors of Outset Medical include Marshall Wace LLP (2.56%), State Street Corp (0.42%), Goldman Sachs Group Inc. (0.25%) and Empowered Funds LLC (0.13%). Insiders that own company stock include Leslie Trigg, Renee Gaeta, John L Brottem, Marc Nash, Steven S Williamson, Jean-Olivier Racine, Nabeel Ahmed, Karen Drexler and D Keith Grossman.
View institutional ownership trends
.

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Outset Medical investors own include Lemonade (LMND), Fulgent Genetics (FLGT), Upstart (UPST), DigitalOcean (DOCN), Appian (APPN), Compass Pathways (CMPS) and Trade Desk (TTD).

Company Calendar

Last Earnings
11/04/2026
Today
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:OM
CIK
1484612
Fax
N/A
Employees
310
Year Founded
2003

Price Target and Rating

High Price Target
$15.00
Low Price Target
$7.00
Potential Upside/Downside
+216.5%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.87)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.65 million
Net Margins
-58.33%
Pretax Margin
-57.76%
Return on Equity
-66.98%
Return on Assets
-28.40%

Debt

Debt-to-Equity Ratio
1.19
Current Ratio
4.86
Quick Ratio
3.85

Sales & Book Value

Annual Sales
$119.48 million
Price / Sales
0.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.41 per share
Price / Book
0.72

Miscellaneous

Outstanding Shares
18,870,000
Free Float
18,401,000
Market Cap
$59.63 million
Optionable
Optionable
Beta
1.93

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:OM) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners